How the AI and quantum revolution will transform drug discovery and medical diagnostics
AI and quantum simulation promise to redefine how to design therapeutics while providing the often lacking datasets needed for better drug development.
Chief Executive Officer of SandboxAQ, the pacesetter in quantitative AI Large Quantitative Models (LQMs). Previously with Alphabet, leading AI and quantum teams. Author of Quantum Computing: An Applied Approach. Serial entrepreneur and Co-Founder of several tech companies, including EarthWeb/Dice (NYSE: DHX). Also co-founded Vista Research, a fintech company. Trustee of the X Prize Foundation and has been a Board Member of Trickle Up, which helps thousands of entrepreneurs start small businesses each year. Has a foundation, The Hidary Foundation, which is dedicated to medical oncology research and has supported work at Sloan Kettering and UCSF. Has been recognized for leadership by organizations such as the World Economic Forum and is a member of YPO. Studied neuroscience at Columbia and subsequently received the Stanley Fellowship in Clinical Neuroscience at NIH, working on functional brain imaging and neural networks.
AI and quantum simulation promise to redefine how to design therapeutics while providing the often lacking datasets needed for better drug development.
Fusing AI and quantum technologies will enable fast data analytics while vastly improving cybersecurity – a game changer for the financial industry.
La tecnología cuántica tendrá muchos impactos desde la ciberseguridad al desarrollo de fármacos. Pero muy pocos países la están desarrollando.
The impact of quantum technology will be far-reaching. But only 17 countries have invested in developing it, creating a divide with serious implications.